Search bioRxiv⌕ Search

Biology subjects

Dudaryeva, O.

Publications and source records attributed to Dudaryeva, O..

2 recordsLinked to original sources

Multi-scale Engineered Vasculature and Hierarchical Porosity via Volumetric Bioprinting-guided Photopolymerization-induced Phase Separation

Vascularization remains a major challenge in hydrogel-based engineered tissues due to the inherent nano-scale porosity of common synthetic and natural biomaterials. Critically, the confinement imposed by the nanoscale network inhibits the outgrowth of blood vessels required for oxygen and nutrient delivery. Despite advancements in biofabrication that enable formation of small channels (0.1-1 mm), achieving vascularization (with capillaries down to 10 {micro}m) throughout cm-scale bioprinted constructs remains a critical bottleneck. Herein, we integrated phase separating cell-interactive gelatin-norbornene hydrogels with volumetric bioprinting to generate architecturally defined centimeter-scale constructs with 0.1-1 mm scale printed channels and interpenetrating micron-scale porosity. Our novel approach allowed us to generate freeform construct designs with light-controllable micron-scale and hierarchical porosity. Importantly, this porosity enabled endothelial cell infiltration and microvessel outgrowth deep into the engineered tissue. Micron-scale vascular structures formed in the pore spaces with feature sizes on the scale of capillaries (<10 {micro}m), crucial to provide oxygen and nutrients to all regions of the hydrogel. The networks remained stable for over 14 days, outperforming classical nanoporous biomaterials. These complex hydrogel-based constructs with engineered multi-scale vascular networks have substantial potential for the generation of actively perfusable advanced tissue models.

bioengineering↗

Novel hepatocyte-like liver organoids recapitulate crucial mature hepatic functions

Accurate liver disease modeling and drug toxicity testing still remain challenging as liver cells in vitro poorly resemble adult hepatocytes, as we previously demonstrated using whole transcriptome and cell identity analysis. To address this, we used our insights into hepatic modeling to develop hepatocyte-like liver organoids (HeLLOs), a novel human organoid model with mature hepatocyte functions superior to existing models. HeLLOs are easily established from (small) healthy or diseased liver tissues and rapidly expanded for an extended period in optimized culture conditions. Transcriptomic and functional analyses revealed that differentiated HeLLOs closely resemble fresh primary human hepatocytes (PHHs) and perform key hepatic functions such as gluconeogenesis, drug metabolism, and bile acid synthesis. We developed a HeLLO-based toxicity assay with higher sensitivity in predicting liver toxicity of known liver-toxic drugs compared to the gold-standard PHHs. By modeling disease-related mechanisms, such as bile acid transport, HeLLOs uncover transport-inhibition toxicity mechanisms of known liver toxic drugs. Single cell sequencing analysis of HeLLOs identified a heterogeneous cluster of cells with cholangiocyte-like and hepatocyte-like cells, overall resembling liver regenerative cells. As such, HeLLOs hold great promise for advancing liver disease modeling and drug testing. To our knowledge, HeLLOs are the best expandable liver model for predicting adverse drug reactions as well as modeling various liver disease mechanisms.

cell biology↗